Finance

Beta
Lists
SRZN:NASDAQ
Surrozen Inc
$25.22
+2.85%
(+0.70) 1D
$25.22
-0.00% (-0.00050)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRZN...
Open
$24.52
High
$26.43
Low
$23.73
Mkt. cap
292.81M
Avg. vol.
104.58K
Volume
1.00M
52-wk high
$35.00
52-wk low
$8.00
EPS
-$35.44
Beta
0.51
Shares outstanding
11.61M
No. of employees
44
Open
$24.52
High
$26.43
Low
$23.73
Mkt. cap
292.81M
Avg. vol.
104.58K
Volume
1.00M
52-wk high
$35.00
52-wk low
$8.00
EPS
-$35.44
Beta
0.51
Shares outstanding
11.61M
No. of employees
44
News stories
From sources across the web
About Surrozen Inc
CEO-
Employees44
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitesurrozen.com
Analyst ratings
Based on 4 analysts giving stock ratings to SRZN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SRZN in the last 3 months.
Highest
Current $25.22
$44.00 (+74.46%)
Average
$43.33 (+71.81%)
Lowest
$42.00 (+66.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
$44.00
+74.5%
05/26/2026
Patrick Dolezal
LifeSci Capital
Buy
Reiterated
$44.00
+74.5%
05/09/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$42.00
+66.5%
05/06/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$40.00
+58.6%
03/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
983.00K
983.00K
528.00K
5.00M
Cost of goods sold
6.04M
7.77M
8.99M
9.33M
Cost of revenue
6.04M
7.77M
8.99M
9.33M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.96M
4.09M
4.18M
6.13M
Operating expense
3.96M
4.09M
4.18M
6.13M
Total operating expenses
10.00M
11.87M
13.17M
15.46M
Operating income
-9.02M
-10.88M
-12.64M
-10.46M
Other non operating income
47.74M
-61.67M
-171.31M
-117.96M
EBT including unusual items
39.75M
-71.64M
-183.16M
-127.50M
EBT excluding unusual items
39.75M
-71.64M
-183.16M
-127.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
39.75M
-71.64M
-183.16M
-127.50M
Net profit margin
4,043.34%
-7,288.20%
-34,689.20%
-2,550.10%
Earnings per share
-1.14
-3.60
-9.62
-4.63
Interest and investment income
1.02M
911.00K
788.00K
912.00K
Interest expense
-
-
-
-
Net interest expenses
1.02M
911.00K
788.00K
912.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.88M
-10.82M
-12.59M
-10.39M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of SRZN
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer